Home
IMUX

IMUX

Immunic Inc.

as of 12-12-2025 3:45pm EST

$0.62

$0.03

-5.17%

Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Chart Type:

Time Range:

Founded:	2016	Country:	United States
Employees:	N/A	City:	NEW YORK
Market Cap:	85.8M	IPO Year:	N/A
Target Price:	$6.00	AVG Volume (30 days):	1.2M
Analyst Decision:	Strong Buy	Number of Analysts:	5
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-0.78	EPS Growth:	N/A
52 Week Low/High:	$0.56 - $1.39	Next Earning Date:	11-13-2025
Revenue:	N/A	Revenue Growth:	N/A
Revenue Growth (this year):	N/A	Revenue Growth (next year):	N/A

AI-Powered IMUX Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold

Model Accuracy: 75.50%

75.50%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full IMUX Forecast & Prediction with Hourly Data

Compare IMUX vs Leading Stocks

See how IMUX stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free IMUX Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "IMUX Immunic Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.